Valuation: Ipca Laboratories Limited

Market Cap 449B 4.69B 4.11B 3.8B 3.51B 6.65B 6.79B 45.66B 17.74B 220B 17.62B 17.23B 763B P/E 2026
35.6x
P/E 2027 * 32x
Enterprise Value 444B 4.64B 4.07B 3.76B 3.47B 6.58B 6.71B 45.15B 17.54B 217B 17.42B 17.04B 754B EV / Sales 2026
4.24x
EV / Sales 2027 * 4.06x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.33%
1 day+0.45%
1 week+2.97%
Current month+4.08%
1 month+8.35%
3 months+22.10%
6 months+12.41%
Current year+24.77%
1 week 1,719.4
Extreme 1719.4
1,812.5
1 month 1,530
Extreme 1530
1,812.5
Current year 1,391.8
Extreme 1391.8
1,812.5
1 year 1,251.6
Extreme 1251.6
1,812.5
3 years 748.95
Extreme 748.95
1,812.5
5 years 669.8
Extreme 669.8
1,812.5
10 years 200
Extreme 200
1,812.5
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+2.97%+21.64%+134.47% 4.67B
+0.11%+0.27%+54.68%+168.60% 1,084B
-0.48%-0.33%+67.76%+64.36% 634B
+0.37%-2.95%+32.92%+88.40% 447B
+0.13%-1.52%+29.35%+26.79% 330B
-8.27%-9.96%+26.33%+28.59% 295B
-0.60%-2.08%+28.51%+46.14% 285B
-0.41%-3.19%-27.46%-39.46% 218B
-1.07%-2.51%+23.02%+62.31% 199B
-1.09%+3.51%+19.99%+79.52% 169B
Average -1.13%+2.66%+27.67%+65.97% 366.45B
Weighted average by Cap. -0.91%+2.48%+39.45%+84.95%

Financials

2026 2027 *
Net sales 96.62B 1.01B 885M 817M 755M 1.43B 1.46B 9.82B 3.82B 47.28B 3.79B 3.71B 164B 108B 1.12B 986M 911M 842M 1.6B 1.63B 10.95B 4.25B 52.7B 4.22B 4.13B 183B
Net income 11.21B 117M 103M 94.78M 87.59M 166M 169M 1.14B 443M 5.48B 440M 430M 19.04B 14B 146M 128M 118M 109M 207M 212M 1.42B 553M 6.85B 549M 537M 23.78B
Net Debt -5.02B -52.4M -45.96M -42.43M -39.21M -74.31M -75.8M -510M -198M -2.46B -197M -192M -8.52B -11.82B -123M -108M -99.99M -92.4M -175M -179M -1.2B -467M -5.79B -464M -454M -20.09B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
09/07/26 1,770.40 +0.45% 96,723
08/07/26 ₹1,762.40 -1.71% 166,406
07/07/26 ₹1,793.10 +0.60% 139,839
06/07/26 ₹1,782.40 +0.20% 393,648
03/07/26 ₹1,778.90 +3.46% 571,448
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,762.40INR
Average target price
1,733.50INR
Spread / Average Target
-1.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock